Skip to main content
logo
Modalis Therapeutics Corporation (TYO:4883)
Japan flag Japan · Delayed Price · Currency is JPY
33.00
0.00 (0.00%)
Aug 27, 2026, 3:30 PM JST

Modalis Therapeutics Financials Overview

Millions JPY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
----401
Revenue Growth
----3900.00%-99.71%
Gross Profit
----401
Operating Income
-2,133-2,211-1,337-2,370-2,063-1,239
Net Income
-2,041-2,152-1,317-2,391-2,702-738
Earnings Per Share
-23.61-27.85-28.55-77.21-92.83-25.67
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
3,0152,8123,5751,8832,9334,936
Total Debt
270--412--
Net Cash (Debt)
2,7452,8123,5751,4712,9334,936
Net Cash Growth
-15.82%-21.34%143.03%-49.85%-40.58%-8.95%
Net Cash Per Share
31.7636.3977.5047.50100.77171.67

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-1,900-2,118-1,432-2,254-1,895-747
Capital Expenditures
-4-2--39-197-107
Free Cash Flow
-1,904-2,120-1,432-2,293-2,092-854
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
----100.00%100.00%
Operating Margin
-----5157.50%-123900.00%
Pretax Margin
-----6765.00%-74400.00%
Profit Margin
-----6755.00%-73800.00%
FCF Margin
-----5230.00%-85400.00%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-15.1215.1215.1243.6817.75
PS Ratio
----244.2417752.87